Here you will find instructions and examples for the most common printing jobs. We think this is a comprehensive list. Please contact us if something you need is missing. General instructions File submissionA digital file submission is always the best option. Grayscales and color images are best represented digitally. We prefer you to submit as a PDF file. This goes for all type of printing jobs.Y

https://www.ehuset.lth.se/en/printing/instructions-and-examples - 2025-06-29

Swedish calendar The E-building events calendar on the Swedish site. It is in Swedish. Page manager: tord [dot] hjalt [at] bme [dot] lth [dot] se (tord[dot]hjalt[at]bme[dot]lth[dot]se)

https://www.ehuset.lth.se/en/calendar - 2025-06-29

Campus overview Street addresses The E building floor plan Floor plan maps at the Department of Computer Science website (Swedish) House Chairman Johan Nilssonhusprefekt [at] ehuset [dot] lth [dot] se (husprefekt[at]ehuset[dot]lth[dot]se)046-222 75 32 House Manager Per-Henrik Rasmussenph [at] ehuset [dot] lth [dot] se (ph[at]ehuset[dot]lth[dot]se)046-222 74 93070-567 16 59 Economist Elisabeth Nord

https://www.ehuset.lth.se/en/contact-and-maps - 2025-06-29

Welcome to the website of the E house Departments and divisions: Biomedical TechnologyComputer ScienceElectrical and Information TechnologyTechnology and Society

https://www.ehuset.lth.se/en/start - 2025-06-29

https://www.ehuset.lth.se/en/form/testwebformpage - 2025-06-29

House Chairman Johan Nilssonhusprefekt [at] ehuset [dot] lth [dot] se (husprefekt[at]ehuset[dot]lth[dot]se)046-222 75 32 House Manager Per-Henrik Rasmussenph [at] ehuset [dot] lth [dot] se (ph[at]ehuset[dot]lth[dot]se)046-222 74 93070-567 16 59 Economist Elisabeth Nordströmekonom [at] ehuset [dot] lth [dot] se (ekonom[at]ehuset[dot]lth[dot]se)046-222 38 28 Postal address Husstyrelsen i E-husetLund

https://www.ehuset.lth.se/en/contact - 2025-06-29

Campus overview Text desciption of campus overview map The E building is here depicted in between the V building in the North, and the M building in the South. The E building is boxed in between the John Ericsson road in the North, Ole Romer's road East, Kommunikations road in the South, and Klas Anselm's road (which is a pedestrian and bicycle road) in the West. There are car parking spaces close

https://www.ehuset.lth.se/en/maps - 2025-06-29

The Board Johan Nilsson, ChairmanStefan Höst, prefekt Electro- and Information TechnologyElin A. Topp, prefekt Computer ScienceIngemar Bengtsson, office director Section of Real Estate ManagementIngrid Svensson, prefekt Biomedical TechnologyMagdalena Unosson, LTH officesElisabeth Nordström, economistMargit Billesö, secretaryJonas Lindemann, LUNARCPer-Henrik Rasmussen, House Manager2-3 student repr

https://www.ehuset.lth.se/en/about - 2025-06-29

Welcome to CREATE Health Our vision: To contribute with innovative diagnostics and therapeutic solutions not for coming generations but for today's CREATE Health aims to provide individualized and improved therapeutic strategies, based on our ability to determine which patient will benefit from a particular treatment. CREATE Health provides solutions to clinical problems by developing innovative d

https://www.createhealth.lth.se/start - 2025-06-29

Centre Management Sara EkCenter Director, Director CanFastersara [dot] ek [at] immun [dot] lth [dot] se (sara[dot]ek[at]immun[dot]lth[dot]se) Corinna RichterResearch Coordinatorcorinna [dot] richter [at] immun [dot] lth [dot] se (corinna[dot]richter[at]immun[dot]lth[dot]se) Board Carl BorrebaeckChairman of the Boardcarl [dot] borrebaeck [at] immun [dot] lth [dot] se (carl[dot]borrebaeck[at]immun[d

https://www.createhealth.lth.se/about/centre-management-and-board - 2025-06-29

Open positions will be advertised on Lund University's website and on our social media channels.If you are a student and interested in doing a Master's or ExJobb project, please contact the PI of the group of interest directly.

https://www.createhealth.lth.se/about/recruitment - 2025-06-29

 Please wait...

https://www.createhealth.lth.se/about/principle-investigators - 2025-06-29

Links will open on the respective websites.Region SkåneMedicon VillageCHUV in LausanneTMUCI in Tianjin, ChinaOslo Cancer ClusterWorking together is an integral part of CREATE Health’s DNA. We can proudly say that CREATE Health’s researchers are highly engaged in many different collaborations and networks – too many to name all of them here. For detailed information on our researchers’ collaborativ

https://www.createhealth.lth.se/research-and-innovation/ongoing-collaborations-and-partners - 2025-06-29

CantargiaCantargia AB was founded in 2009/2010 by Thoas Fioretos and Marcus Järås (Lund University), Kjell Sjöström (Innovagen), and by LU Bioscience. The company specializes in antibody-based cancer therapy. After initially focusing on treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer (PDAC), new antibodies designed for the treatment of autoimmune and inflammatory diseases hav

https://www.createhealth.lth.se/research-and-innovation/spin-outs - 2025-06-29

The Translational Cancer Faster Forward doctoral/postdoctoral programmes (2018-2025). The CanFaster programme is supported by the European Union’s Marie Skłodowska-Curie COFUND programme (Horizon 2020 framework) based on the "Mobility across borders" philosophy. The CanFaster programme has attracted international PhD and Postdoc fellows (ER) with an interest in applied medical research in oncology

https://www.createhealth.lth.se/canfaster - 2025-06-29

The links below open on the respective publication website.In vivo dendritic cell reprogramming for cancer immunotherapy.Authors: Ascic, E., Catena, X., et al.Publication: Science 386, 6719Year: 2024Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab.Authors: Meng, P., Dalal, H., Chen, Y., Brueffer, C., Gladchuk, S., Alcaide, M., ... &

https://www.createhealth.lth.se/canfaster/publications - 2025-06-29

Inducing anti-tumor immunity with in-situ direct reprograming of cancer cells to cDC1sNext generation immuno-oncological targets for cancer therapySubtype-dependent biomarkers for systemic therapy in bladder cancer

https://www.createhealth.lth.se/canfaster/ongoing-canfaster-postdoc-projects - 2025-06-29

Immunotherapy has transformed the cancer treatment landscape leading to long-term responses. However, these strategies are effective in a limited number of patients and often lose their efficacy as the tumor progresses. Insufficient antigen presentation mediated by MHC downregulation and exclusion of functional antigen-presenting cells (APCs) from the tumor microenvironment (TME) are critical evas

https://www.createhealth.lth.se/canfaster/ongoing-canfaster-postdoc-projects/inducing-anti-tumor-immunity-situ-direct-reprograming-cancer-cells-cdc1s - 2025-06-29

Immuno-oncological (I-O) treatment methods have revolutionized cancer therapy and tremendous clinical benefits are achieved in some cancer patients. However, today a limited number of I-O drug targets are used and only a fraction of all cancer patients has a therapeutic response. We need to further understand the immune system in cancer in order to develop novel treatment strategies and improve su

https://www.createhealth.lth.se/canfaster/ongoing-canfaster-postdoc-projects/next-generation-immuno-oncological-targets-cancer-therapy - 2025-06-29

Cancer in the urinary bladder afflicts around 3000 persons per year in Sweden, most often older men and smokers. Despite being a quite common cancer type it is an understudied cancer type considering the burden to society and health outcomes [1].To patients with superficial cancer limited to the mucosa of the urinary bladder, the prognosis is good, but once the tumor has grown into the muscle-laye

https://www.createhealth.lth.se/canfaster/ongoing-canfaster-postdoc-projects/subtype-dependent-biomarkers-systemic-therapy-bladder-cancer - 2025-06-29